Pharmaceutical Waste Coupler for Unrecoverable Drug Disposal

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for a system to properly dispose of residual pharmaceutical compositions to prevent drug diversion and ensure safe disposal, as improper disposal can lead to unauthorized use or ingestion.

Innovation Solution

A pharmaceutical waste system that includes a coupler to connect a dispenser to an extraction stage, which uses a pump to transfer residual pharmaceuticals through a chemical and physical treatment process, separating and deactivating the drugs to render them unrecoverable.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If residual pharmaceutical composition is disposed of through simple methods, then disposal speed is fast, but drug diversion and improper usage risks increase

Engineering Contradiction:
Improvedisposal safetyVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The disposal system is segmented into distinct functional modules: extraction stage with pump, chemical treatment stage with separate chambers for different reagents, and physical treatment stage. Each module performs a specific function in the disposal sequence, allowing independent optimization and maintenance while ensuring comprehensive treatment of residual pharmaceuticals

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system performs preliminary extraction of residual pharmaceutical composition from dispensers before treatment. The pump-based extraction stage removes pharmaceuticals from various dispenser types (IV bags, syringes, cartridges) and concentrates them into a treatment reservoir, preparing the material for subsequent chemical and physical deactivation processes

Inventive Principle:
Principle #10Preliminary action

2Reliability

If chemical and physical treatment processes are applied, then drug deactivation is complete, but treatment time increases

Engineering Contradiction:
Improvedeactivation effectivenessVSAvoiddisposal time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The system implements continuous flow through the treatment process. The pump maintains constant fluid movement from extraction through chemical treatment to physical treatment stages, eliminating idle time between processes. Chemical reagents are continuously introduced and mixed, ensuring uninterrupted deactivation action throughout the system

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The treatment process uses periodic introduction of chemical reagents in controlled cycles. Different chemical agents are added in sequence with specific mixing and reaction periods, allowing optimal deactivation at each stage while maintaining overall process efficiency and preventing reagent waste

Inventive Principle:
Principle #19Periodic action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system effectively prevents drug diversion by ensuring safe and complete disposal of residual pharmaceuticals, rendering them unusable through chemical and physical treatment.

Implementation Method 1

which uses a pump to transfer residual pharmaceuticals

Methodology Applied
Scientific EffectPumping: Pump

Implementation Method 2

treating at least a portion of the extracted pharmaceutical composition in one of a chemical and physical manner

Methodology Applied
Scientific EffectChemical treatment: Chemical Bonding

Data Source

PatentUS12434282B2Pharmaceutical waste system
Publication Date: 2025.10.07 STRYKER CORP
  • US12434282B2 patent drawing
  • US12434282B2 patent drawing
  • US12434282B2 patent drawing

AI summary

A method of disposing of a residual pharmaceutical composition from an IV bag includes coupling the IV bag to a pharmaceutical dispenser coupler. The method also includes extracting at least a portion of the residual pharmaceutical composition from the IV bag through the pharmaceutical dispenser coupler. The method further includes treating at least a portion of the extracted pharmaceutical composition in one of a chemical and physical manner.